Finding early signs of Charcot-Marie-Tooth 1A
Treatments studied
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You either have genetically confirmed CMT1A or have a parent with it
- You can walk, with or without help
- You must be at least 30 kg (66 lbs) in weight
- You must not have any other nerve or muscle diseases
- You must not be pregnant or breastfeeding
- You must be able to read and understand French well enough to give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special vibration device to an intensive rehab program helps improve balance in people with Charcot-Marie-Tooth disease type 1A. If you are between 18 and 65 and have mild to moderate leg weakness, you may be able to join.
This trial tests a new medicine called EDK060 for people with Charcot-Marie-Tooth disease type 1A (CMT1A). The study will check if the drug is safe and how the body processes it, with the goal of finding better treatments for this condition.
This trial tests a new cell therapy called EN001 for people with CMT1A. It aims to see if the treatment is safe and can help with nerve function and muscle weakness.
This study uses MRI scans to look at nerve and muscle changes over time in people with inherited or acquired nerve conditions. It may help doctors better understand how these diseases progress.
This study looks for new markers of early Charcot-Marie-Tooth 1A (CMT1A) disease using blood tests and special MRI scans. It aims to help understand how the disease progresses and may lead to better treatments.
This study is looking for people with Charcot-Marie-Tooth disease (a nerve condition) and healthy volunteers to track long-term changes in the body. Researchers want to see if certain biomarkers (measurable signs) can help predict how CMT progresses over time.
Hear when a new Charcot-Marie-Tooth Disease Type 1A trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.